American Burn Association Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2013
NCT01902810
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

American Burn Association